FIELD: medicine, in particular immunology.
SUBSTANCE: claimed method includes administration intramuscularly of recombinant yeast liquid vaccine against HBV, and ones immunomodulator affinoendolysin in dose of 0.1 U/year of infant age is subcutaneously administered.
EFFECT: increased T-helper lymphocyte activation; increased populations of CD16 and CD4 lymphocytes; increased levels of specific antibodies against HBV; prolonged postvaccinal immunity.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF HEPATITIS REVACCINATION IN CHILDREN WITH ONCOLOGIC DISEASES IN PAST HISTORY | 2008 |
|
RU2379053C2 |
METHOD OF ACUTE RESPIRATORY DISEASES PREVENTION DURING POSTVACCINAL PERIOD FOR CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS AND CHRONIC RENAL INSUFFICIENCY | 2005 |
|
RU2325182C2 |
METHOD OF FORMING POST-VACCINATION IMMUNE AGAINST INFLUENZA VIRUS IN PATIENTS WITH GENERAL VARIABLE IMMUNE DEFICIENCY | 2022 |
|
RU2800858C1 |
ANTIVIRAL PREPARATION AND METHOD OF PREPARING IMMUNOGLOBULIN FOR PROPHYLAXIS AND TREATMENT OF PATIENT WITH VIRAL DISEASES | 1999 |
|
RU2144379C1 |
METHOD FOR PROPHYLAXIS OF POST-VACCINAL COMPLICATIONS | 2006 |
|
RU2316343C2 |
METHOD FOR PREDICTION OF COMPLICATED VACCINAL PERIOD FOR CHILDREN WITH UNFAVOURABLE PREMORBID BACKGROUND | 2017 |
|
RU2639128C1 |
METHOD FOR PREVENTION OF REDUCED POSTVACCINAL HUMORAL IMMUNITY TO DIPHTHERIA AND PERTUSSIS IN SCHOOLCHILDREN OF 7-12 YEARS OLD, ASSOCIATED WITH UNFAVOURABLE ENVIRONMENTAL FACTORS | 2024 |
|
RU2826768C1 |
METHOD FOR SELECTING CHILDREN FOR RENEWED VACCINATION AGAINST MEASLES | 0 |
|
SU1801212A3 |
METHOD FOR MEASLES, MUMPS, RUBELLA VACCINATION FOR HIV-INFECTED CHILDREN | 2016 |
|
RU2616234C1 |
METHOD FOR PREVENTING INFLUENZA BY COMBINED APPLICATION OF INTERFERON GAMMA AND INACTIVATED ANTI-INFLUENZA VACCINE | 2011 |
|
RU2546540C2 |
Authors
Dates
2007-02-27—Published
2005-06-27—Filed